Back to Search
DONNA FERRERO, M.D.
M.D.
Physical Medicine & Rehabilitation Physician
NPI: 1306881339IndividualAccepts Medicare
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
226012(NY)
CMS Specialties
PrimaryPHYSICAL MEDICINE AND REHABILITATION
Education
OTHER
Class of 1994
Research & Publications (20)
Typical 2-Cys peroxiredoxins--modulation by covalent transformations and noncovalent interactions.
PMID 19476489·FEBS J·2009
6-review
Increase of telomerase activity and hTERT expression in myelodysplastic syndromes.
PMID 19270495·Cancer Biol Ther·2009
8-other
Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low/intermediate risk myelodysplastic syndromes.
PMID 19036104·Br J Haematol·2009
3-trial
Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium.
PMID 18449069·Sex Transm Dis·2008
6-review
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib.
PMID 18057228·Blood·2008
7-preclinical
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.
PMID 17379077·Exp Hematol·2007
8-other
Corticosteroids can reverse severe imatinib-induced hepatotoxicity.
PMID 16785130·Haematologica·2006
8-other
Health indicators among low income women who report a history of sex work: the population based Northern California Young Women's Survey.
PMID 16199746·Sex Transm Infect·2005
8-other
HIV-related risk behavior among Hispanic immigrant men in a population-based household survey in low-income neighborhoods of northern California.
PMID 16041250·Sex Transm Dis·2005
4-observational
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
PMID 15716989·Leukemia·2005
8-other
Use of multiple nucleic acid amplification tests to define the infected-patient "gold standard" in clinical trials of new diagnostic tests for Chlamydia trachomatis infections.
PMID 15472336·J Clin Microbiol·2004
8-other
Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.
PMID 15136232·Haematologica·2004
8-other
The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.
PMID 15107628·Sex Transm Dis·2004
4-observational
Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571.
PMID 14726674·Cancer Biol Ther·2004
8-other
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
PMID 12743153·J Clin Oncol·2003
8-other
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens.
PMID 12517865·J Clin Microbiol·2003
4-observational
Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +- alpha-interferon.
PMID 11237066·Leukemia·2001
8-other
Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs.
PMID 11230419·J Clin Microbiol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1445 PORTLAND AVENUE, SUITE #309
ROCHESTER, NY 14621 - Phone
- (585) 342-2638
Quick Facts
- NPI
- 1306881339
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile